Stock CCRN CROSS COUNTRY HEALTHCARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Employment Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
17.14 USD -1.49% Intraday chart for Cross Country Healthcare, Inc. -2.06% -24.29%
Apr. 25 Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey CI
Feb. 27 Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 428.5 333.2 1,055 990.9 795.8 594.4 - -
Enterprise Value (EV) 1 498.5 385 1,230 1,136 778.7 540 485.3 439.3
P/E ratio -7.22 x -24.6 x 7.86 x 5.29 x 11 x 18.1 x 13.9 x 11.7 x
Yield - - - - - - - -
Capitalization / Revenue 0.52 x 0.4 x 0.63 x 0.35 x 0.39 x 0.4 x 0.39 x 0.36 x
EV / Revenue 0.61 x 0.46 x 0.73 x 0.4 x 0.39 x 0.36 x 0.32 x 0.27 x
EV / EBITDA 19.6 x 10.6 x 7.59 x 3.77 x 5.39 x 7.24 x 5.37 x 4.38 x
EV / FCF 192 x 17 x -13.3 x 9.07 x 3.32 x 6.1 x 5.74 x -
FCF Yield 0.52% 5.87% -7.54% 11% 30.1% 16.4% 17.4% -
Price to Book 2.56 x 2.08 x 3.45 x 2.11 x 1.64 x 1.17 x 1.09 x 1.01 x
Nbr of stocks (in thousands) 36,877 37,563 38,004 37,295 35,151 34,677 - -
Reference price 2 11.62 8.870 27.76 26.57 22.64 17.14 17.14 17.14
Announcement Date 3/4/20 2/24/21 2/23/22 2/22/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 822.2 836.4 1,677 2,807 2,020 1,482 1,537 1,630
EBITDA 1 25.47 36.32 162.1 301.7 144.4 74.63 90.37 100.2
EBIT 1 5.967 18.25 145.3 321.7 126.1 46.71 57.67 70.27
Operating Margin 0.73% 2.18% 8.67% 11.46% 6.24% 3.15% 3.75% 4.31%
Earnings before Tax (EBT) 1 -24.21 -12.33 133.2 256.3 102.9 45.32 59.66 82.1
Net income 1 -57.71 -12.96 132 188.5 72.63 32.25 42.97 58.29
Net margin -7.02% -1.55% 7.87% 6.71% 3.6% 2.18% 2.8% 3.58%
EPS 2 -1.610 -0.3600 3.530 5.020 2.050 0.9463 1.236 1.461
Free Cash Flow 1 2.602 22.59 -92.79 125.3 234.5 88.52 84.52 -
FCF margin 0.32% 2.7% -5.53% 4.46% 11.61% 5.97% 5.5% -
FCF Conversion (EBITDA) 10.22% 62.19% - 41.52% 162.39% 118.61% 93.53% -
FCF Conversion (Net income) - - - 66.47% 322.9% 274.49% 196.7% -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/4/20 2/24/21 2/23/22 2/22/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 374.9 640.7 788.7 753.6 636.1 628.2 622.7 540.7 442.3 414 374.4 362.7 366.3 378.3 387.8
EBITDA 1 30.13 80.93 97.41 83.49 63.79 57.03 52.14 44.44 27.25 20.59 15.44 16.56 19.5 23.11 22.04
EBIT 1 25.68 76.58 93.09 77.9 59.09 62.38 39.68 40.01 22.71 16.12 8.844 9.796 12.27 15.92 15.23
Operating Margin 6.85% 11.95% 11.8% 10.34% 9.29% 9.93% 6.37% 7.4% 5.13% 3.89% 2.36% 2.7% 3.35% 4.21% 3.93%
Earnings before Tax (EBT) 1 24.64 73.3 87.12 74.15 48.7 46.35 40.12 30.31 19.5 12.97 8.31 8.928 12.57 16.12 17.02
Net income 1 23.43 77.57 61.98 52.89 34.79 38.79 29.44 21.34 12.81 9.038 5.575 6.289 8.788 11.76 11.82
Net margin 6.25% 12.11% 7.86% 7.02% 5.47% 6.17% 4.73% 3.95% 2.9% 2.18% 1.49% 1.73% 2.4% 3.11% 3.05%
EPS 2 0.6200 2.070 1.630 1.400 0.9300 1.050 0.8100 0.6000 0.3600 0.2600 0.1623 0.1894 0.2585 0.3374 0.2899
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/3/21 2/23/22 5/4/22 8/3/22 11/2/22 2/22/23 5/3/23 8/2/23 11/1/23 2/21/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 69.9 51.8 175 145 - - - -
Net Cash position 1 - - - - 17.1 54.4 109 155
Leverage (Debt/EBITDA) 2.746 x 1.426 x 1.082 x 0.481 x - - - -
Free Cash Flow 1 2.6 22.6 -92.8 125 235 88.5 84.5 -
ROE (net income / shareholders' equity) 2.81% 10.6% 50.7% 52.4% 17% 10.1% 6.95% 7.43%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 4.530 4.270 8.040 12.60 13.80 14.70 15.80 17.00
Cash Flow per Share 2 0.1500 0.7500 -2.290 3.570 7.000 2.400 1.900 -
Capex 1 2.94 4.62 7.17 8.79 14 8.95 11.5 14
Capex / Sales 0.36% 0.55% 0.43% 0.31% 0.69% 0.6% 0.75% 0.86%
Announcement Date 3/4/20 2/24/21 2/23/22 2/22/23 2/21/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Cross Country Healthcare, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
17.14 USD
Average target price
19.5 USD
Spread / Average Target
+13.77%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Employment Services

1st Jan change Capi.
CROSS COUNTRY HEALTHCARE, INC. Stock Cross Country Healthcare, Inc.
-24.29% 594M
RANDSTAD N.V. Stock Randstad N.V.
-18.14% 8.79B
ROBERT HALF INTERNATIONAL, INC Stock Robert Half International, Inc
-21.12% 7.17B
ADECCO GROUP AG Stock Adecco Group AG
-22.90% 5.83B
MANPOWERGROUP INC. Stock ManpowerGroup Inc.
-4.56% 3.67B
PERSOL HOLDINGS CO.,LTD. Stock Persol Holdings Co.,Ltd.
-8.96% 3.14B
STERLING CHECK CORP. Stock Sterling Check Corp.
+9.91% 1.5B
SHANGHAI FOREIGN SERVICE HOLDING GROUP CO., LTD. Stock Shanghai Foreign Service Holding Group Co., Ltd.
+2.08% 1.54B
FESCO GROUP CO., LTD. Stock FESCO Group Co., Ltd.
+0.59% 1.47B
KFORCE INC. Stock Kforce Inc.
-5.08% 1.2B
Other Employment Services
  1. Stock Market
  2. Equities
  3. CCRN Stock
  4. Financials Cross Country Healthcare, Inc.